Abstract:Cytochrome P450 2D6 (CYP2D6) is an enzyme that is involved in the metabolism of roughly 25% of all marketed drugs and therefore belongs to the most important enzymes in drug metabolism. CYP2D6 features a high degree of genetic polymorphism that can significantly affect the metabolic activity of an individual. In extreme cases, structural changes at the level of single amino acids can either increase its enzymatic activity abolishing the drug therapeutic effect or completely disable the enzyme and elevate drug plasma level potentially leading to adverse effects. In this study, starting from the crystal structure, we built a full-length membrane-anchored all-atom model of the wild-type CYP2D6 as well as five of its variants differing in the enzymatic activity. We validated our models with available experimental data and compared their structural properties with molecular dynamics simulations. The main focus of this study was to identify differences that could mechanistically explain the altered activity of the variants and improve our understanding of their functioning. We observed differences in the opening frequencies and minimal diameters of tunnels that connect the buried active site to the surrounding solvent environment. The variants CYP2D6*4 and CYP2D6*10 associated with missing or decreased activity showed less frequent opening of the tunnels compared to the wild-type. Both CYP2D6*10 and CYP2D6*17 showed a deprivation of an important ligand tunnel suggesting a feasible reason for their altered substrate specificity. Next, the altered fold at the N-terminal anchor region and the decreased active site volume caused by the amino acid mutations of the CYP2D6*4 variant offer an explanation for the absence of its metabolic activity. The mutations in CYP2D6*53 contributed to a significant enlargement of an important ligand tunnel and an extension of the active site cavity. This could explain the altered metabolic profile as well as the enhanced metabolic rates of this particular variant supporting its designation as a possible cause for the ultrarapid metabolizer phenotype. We believe these novel structural insights could advance the fields of personalized medicine and enzyme engineering. Furthermore, they could aid in guiding laboratory as well as computational experiments in the future.

A Highly Active Single-Mutation Variant of P450BM3 (CYP102A1).

Structural Basis for the Properties of Two Single-Site Proline Mutants of Cyp102a1 (P450(bm3))

Structure, Electronic Properties and Catalytic Behaviour of an Activity-Enhancing CYP102A1 (P450BM3) Variant

Mechanism Evaluation for an Amino Acid Substitution P.y246c of B‐glycosyltransferase Enzyme with Bweak Phenotype

Molecular Determinants of Substrate Affinity and Enzyme Activity of a Cytochrome P450BM3 Variant

Physical and chemical properties of Δ3−12 cysteine-depleted cytocrome P450 3A4 with amino acid substitution of S291C

Influence Of Various Polymorphic Variants Of Cytochrome P450 Oxidoreductase (Por) On Drug Metabolic Activity Of Cyp3a4 And Cyp2b6

Improving the Activity of Cytochrome P450 BM-3 Catalyzing Indole Hydroxylation by Directed Evolution

Amino Acid Mutation Effect on Indole-Hydroxylating Ability of Cytochrome P450 BM-3

Proline-40 is Essential to Maintaining Cytochrome B^5's Stability and Its Electron Transfer with Cytochrome C

Cytochrome P450BM-3 Mutants With Improved Catalytic Properties of Hydroxylating Indole to Indigo by Error-prone PCR

Semirational Protein Engineering of CYP153AM.aq. -CPRBM3 for Efficient Terminal Hydroxylation of Short- to Long-Chain Fatty Acids

Semi-rational Molecular Engineering to Improve Thermostability of Cytochrome P450 BM-3

Molecular Dynamics Simulations Reveal Structural Differences among Allelic Variants of Membrane-Anchored Cytochrome P450 2D6

Mutations Selectively Evolving Peroxidase Activity Among Alternative Catalytic Functions of Human Glutathione Transferase P1-1

Modeling of 3D Structure of Cytochrome P450BM3 Evolved Enzyme

Cross-Linking Mass Spectrometry and Mutagenesis Confirm the Functional Importance of Surface Interactions Between CYP3A4 and Holo/Apo Cytochrome B5

Deep mutational scanning of CYP2C19 in human cells reveals a substrate specificity-abundance tradeoff

A Novel A105Y Mutant of CYP17A1 Exhibits Almost Perfect Regioselectivity in the Production of 17α-Hydroxyprogesterone

Identification of Proline Residues in or Near the Transmembrane Helices of the Human Breast Cancer Resistance Protein (bcrp/abcg2) That Are Important for Transport Activity and Substrate Specificity

Tuning peroxidase activity of artificial P450 peroxygenase by engineering redox-sensitive residues